|
SodA peptide sequences used in immune recognition assays |
|||||
| Peptide |
Position |
Peptide sequence |
Peptide |
Position |
Peptide sequence |
|
|
|||||
| 1 |
1–15 |
VAEYTLPDLDWDYGA |
21 |
101–115 |
DAFGSFDKFRAQFHA |
| 2 |
6–20 |
LPDLDWDYGALEPHI |
22 |
106–120 |
FDKFRAQFHAAAT TV |
| 3 |
11–25 |
WDYGALEPHISGQIN |
23 |
111–125 |
AQFHAAAT TVQGSGW |
| 4 |
16–30 |
LEPHISGQINELHHS |
24 |
116–130 |
AAT TVQGSGWAALGW |
| 5 |
21–35 |
SGQINELHHSKHHAT |
25 |
121–135 |
QGSGWAALGWDTLGN |
| 6 |
26–40 |
ELHHSKHHATYVKGA |
26 |
126–140 |
AALGWDTLGNKLLIF |
| 7 |
31–45 |
KHHATYVKGANDAVA |
27 |
131–145 |
DTLGNKLLIFQVYDH |
| 8 |
36–50 |
YVKGANDAVAKLEEA |
28 |
136–150 |
KLLIFQVYDHQTNFP |
| 9 |
41–55 |
NDAVAKLEEARAKED |
29 |
141–155 |
QVYDHQTNFPLGIVP |
| 10 |
46–60 |
KLEEARAKEDHSAIL |
30 |
146–160 |
QTNFPLGIVPLLLLD |
| 11 |
51–65 |
RAKEDHSAILLNEKN |
31 |
151–165 |
LGIVPLLLLDMWEHA |
| 12 |
56–70 |
HSAILLNEKNLAFNL |
32 |
156–170 |
LLLLDMWEHAFYLQY |
| 13 |
61–75 |
LNEKNLAFNLAGHVN |
33 |
161–175 |
MWEHAFYLQYKNVKV |
| 14 |
66–80 |
LAFNLAGHVNHT IWW |
34 |
166–180 |
FYLQYKNVKVDFAKA |
| 15 |
71–85 |
AGHVNHT IWWKNLSP |
35 |
171–185 |
KNVKVDFAKAFWNVV |
| 16 |
76–90 |
HT IWWKNLSPNGGDK |
36 |
176–190 |
DFAKAFWNVVNWADV |
| 17 |
81–95 |
KNLSPNGGDKPTGEL |
37 |
181–195 |
FWNVVNWADVQSRYA |
| 18 |
86–100 |
NGGDKPTGELAAAIA |
38 |
186–200 |
NWADVQSRYAAATSQ |
| 19 |
91–105 |
PTGELAAAIADAFGS |
39 |
191–205 |
QSRYAAATSQTKGLI |
| 20 |
96–110 |
AAAIADAFGSFDKFR |
40 |
193–207 |
RYAAATSQ TKGLIFG |
Allen et al. Respiratory Research 2008 9:36 doi:10.1186/1465-9921-9-36 |
|||||